RA

Rosalind Advisors Portfolio holdings

AUM $207M
1-Year Est. Return 62.29%
This Quarter Est. Return
1 Year Est. Return
+62.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$186M
AUM Growth
+$34.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1 +$10.6M
2 +$9.27M
3 +$8.15M
4
FENC icon
Fennec Pharmaceuticals
FENC
+$7.96M
5
VSTM icon
Verastem
VSTM
+$4.65M

Top Sells

1 +$11.9M
2 +$7.86M
3 +$5.8M
4
OTLK icon
Outlook Therapeutics
OTLK
+$2.4M
5
CYBN
Cybin
CYBN
+$2.33M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$31.9M 16.32%
2,650,389
2
$19.3M 9.88%
2,998,945
-22,446
3
$11.2M 5.72%
628,050
4
$10.6M 5.43%
+3,050,000
5
$10.5M 5.38%
3,104,995
6
$10.1M 5.14%
1,805,390
-26,610
7
$9.64M 4.93%
1,128,700
+243,700
8
$9.27M 4.74%
+870,000
9
$8.15M 4.17%
+2,654,944
10
$7.96M 4.07%
+1,259,876
11
$7.15M 3.66%
810,918
-264,187
12
$6.97M 3.56%
150,000
-125,000
13
$6.56M 3.36%
2,495,783
-18,263
14
$5.86M 3%
876,996
+324,496
15
$5.2M 2.66%
692,185
+206,212
16
$4.65M 2.38%
+900,000
17
$4.38M 2.24%
1,062,500
+312,500
18
$3.15M 1.61%
+260,000
19
$3.09M 1.58%
1,018,021
+338,853
20
$2.67M 1.37%
707,625
-73,798
21
$2.57M 1.32%
303,864
22
$1.49M 0.76%
+252,753
23
$985K 0.5%
+417,400
24
$885K 0.45%
811,918
+316,428
25
$827K 0.42%
250,555
-5,000